Search Medical Condition
Please enter condition
Please choose location

Garner, North Carolina Clinical Trials

A listing of Garner, North Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (145) clinical trials

Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease

This is a Phase 3, multi-center, double-masked, randomized, vehicle-controlled, parallel-group study designed to evaluate the safety and efficacy of KPI-121 0.25% ophthalmic suspension versus vehicle in subjects with dry eye disease.

Phase

3.77 miles

Learn More »

Do You Experience Heavy Menstrual Bleeding and Pain? Wake Research Associates is enrolling volunteers in a research study testing an investigational medication for heavy menstrual bleeding and pain due to Uterine Fibroids.

Phase N/A

3.77 miles

Learn More »

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. Wake Research Associates is enrolling volunteers in a study testing the effectiveness, and safety of an investigational medication for individuals with NASH and associated bridging fibrosis.

Phase N/A

3.77 miles

Learn More »

It's a disorder, not a decision. If you're one of the many people who has binge eating disorder (B.E.D.), you may feel embarrassment and guilt after eating an excessive amount of food in a set period of time. If you are diagnosed with B.E.D., you may be eligible to participate ...

Phase N/A

3.77 miles

Learn More »

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. If you have a condition called compensated cirrhosis from NASH, Wake Research Associates is enrolling volunteers in a study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

3.77 miles

Learn More »

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

This is a randomized (the study medication is assigned by chance), double-blind (neither physician nor participant knows the identity of the assigned treatment), placebo (an inactive substance that is compared with a drug to test whether the drug has a real effect)-controlled, event-driven, multicenter study in patients who are hospitalized ...

Phase

5.9 miles

Learn More »